# Minoxidil

```text
DRUG INFORMATION

  ADULT
    - Patients over 12 years of age: The recommended initial dosage of minoxidil tablets
      is 5 mg given as a single daily dose.
      Source: US FDA label for minoxidil (Minoxidil), section 'dosage and
      administration', retrieved 2026-08-29
    - Daily dosage can be increased to 10 mg, 20 mg and then to 40 mg in single or
      divided doses if required for optimum blood pressure control.
      Source: US FDA label for minoxidil (Minoxidil), section 'dosage and
      administration', retrieved 2026-08-29
    - The effective dosage range is usually 10 mg to 40 mg per day.
      Source: US FDA label for minoxidil (Minoxidil), section 'dosage and
      administration', retrieved 2026-08-29

  CHILD
    - 9. Pediatric Use Use in pediatric patients has been limited to date, particularly
      in infants. The recommendations under DOSAGE AND ADMINISTRATION can be considered
      only a rough guide at present and a careful titration is essential.
      Source: US FDA label for minoxidil (Minoxidil), section 'pediatric use', retrieved
      2026-08-29
    - Patients over 12 years of age: The recommended initial dosage of minoxidil tablets
      is 5 mg given as a single daily dose. Daily dosage can be increased to 10 mg, 20
      mg and then to 40 mg in single or divided doses if required for optimum blood
      pressure control. The effective dosage range is usually 10 mg to 40 mg per day.
      The maximum recommended dosage is 100 mg per day.
      Source: US FDA label for minoxidil (Minoxidil), section 'dosage and
      administration', retrieved 2026-08-29
    - Patients over 12 years of age: The recommended initial dosage of minoxidil tablets
      is 5 mg given as a single daily dose.
      Source: US FDA label for minoxidil (Minoxidil), section 'dosage and
      administration', retrieved 2026-08-29

  RENAL IMPAIRMENT
    - No kidney-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for minoxidil (Minoxidil),
      retrieved 2026-08-29

  HEPATIC IMPAIRMENT
    - No liver-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for minoxidil (Minoxidil),
      retrieved 2026-08-29

  PREGNANCY
    - Pregnancy Teratogenic Effects Pregnancy Category C.
      Source: US FDA label for minoxidil (Minoxidil), section 'pregnancy', retrieved
      2026-08-29
    - Oral administration of minoxidil has been associated with evidence of increased
      fetal resorption in rabbits, but not rats, when administered at five times the
      maximum recommended oral antihypertensive human dose.
      Source: US FDA label for minoxidil (Minoxidil), section 'pregnancy', retrieved
      2026-08-29
    - There was no evidence of teratogenic effects in rats and rabbits.
      Source: US FDA label for minoxidil (Minoxidil), section 'pregnancy', retrieved
      2026-08-29

  BREASTFEEDING
    - Nursing Mothers There has been one report of minoxidil excretion in the breast
      milk of a woman treated with 5 mg oral minoxidil twice daily for hypertension.
      Source: US FDA label for minoxidil (Minoxidil), section 'nursing mothers',
      retrieved 2026-08-29
    - Because of the potential for adverse effects in nursing infants from minoxidil
      absorption, minoxidil should not be administered to a nursing woman.
      Source: US FDA label for minoxidil (Minoxidil), section 'nursing mothers',
      retrieved 2026-08-29
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)